HB388 amends Kentucky’s business corporation law to change the standards governing corporate directors’ duties and liability, with a particular focus on diversity, equity, and inclusion (DEI) initiatives and environmental, social, and governance (ESG) investing. The bill preserves the general rule that directors must act in good faith, on an informed basis, and in the best interests of the corporation, but it adds language stating that a director is not acting in good faith if the director takes action to implement or maintain DEI initiatives or ESG investing. It also excludes those topics from certain liability protections and from the business judgment rule in derivative actions when damages are alleged to result from such initiatives or investing strategies.
The bill further defines “DEI initiatives” and “ESG investing,” while carving out exceptions for conduct required by state or federal antidiscrimination laws and for differential treatment necessary to provide medical treatment. It also preserves and clarifies rules for public benefit corporations, including the balancing of shareholder interests with public benefits, and it raises the threshold for shareholder derivative actions in public benefit corporations seeking to enforce those requirements.
In practical terms, HB388 would alter Kentucky’s corporate governance framework by exposing directors to greater potential liability when corporate decisions involve DEI or ESG-related policies, and by limiting defenses available in shareholder suits tied to those decisions. It would affect directors, officers, shareholders, and corporations organized under Kentucky law, especially public benefit corporations and companies that use DEI or ESG criteria in employment, contracting, or investment decisions.
Because there are no committee transcripts or recorded votes provided, the overall sentiment cannot be measured from legislative debate or roll call history. Based on the bill text alone, the measure appears designed to restrict corporate DEI and ESG practices and to create stronger legal consequences for directors who authorize or maintain them, suggesting a policy direction that is likely to be viewed favorably by opponents of DEI/ESG programs and unfavorably by supporters of those programs.
The main point of contention is the bill’s treatment of DEI and ESG as grounds for director liability and as exceptions to ordinary business-judgment protections. Supporters would likely argue that it prevents corporations from adopting politically driven policies that may harm shareholders, while critics would likely contend that it interferes with board discretion, chills lawful diversity and sustainability efforts, and could create uncertainty for corporations trying to comply with broader legal and market expectations.
HB388 would amend KRS 271B.8-300 and KRS 271B.7-400 to narrow directors’ protections and reshape derivative litigation rules in Kentucky business corporation law. It would create statutory definitions for DEI initiatives and ESG investing, remove ordinary good-faith and business-judgment protections for actions involving those topics, and authorize enhanced remedies in shareholder derivative suits where damages are alleged to stem from DEI or ESG decisions. It also adjusts derivative-action requirements for public benefit corporations, including a higher ownership threshold for shareholders seeking to enforce public-benefit obligations.
No committee discussion or vote record was provided, so there is no documented legislative sentiment to summarize from debate or roll calls. From the bill language itself, the measure is clearly framed as a restriction on DEI and ESG practices in corporate governance, indicating a likely supportive stance among lawmakers favoring limits on those practices and likely opposition from those who view the bill as an intrusion into board management and lawful corporate policy choices.
The central controversy is whether the bill appropriately protects shareholders from corporate DEI and ESG policies or improperly politicizes corporate governance. Supporters are likely to argue that directors should not receive broad liability protection when adopting DEI or ESG strategies that may conflict with shareholder interests. Opponents are likely to argue that the bill singles out lawful corporate policies, undermines board discretion, and may conflict with existing antidiscrimination obligations, business judgment principles, and public-benefit corporation structures. The bill’s exceptions for legally required antidiscrimination measures and medical treatment also suggest concern about overbreadth and implementation.